Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ore Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (1)	2/13/2008 12:52:50 PM
From: Mike McFarland	Respond to of 50

RENAISSANCE TECHNOLOGIES LLC SC 13G 2/13/2008 and there is one there from a week ago, DIMENSIONAL FUND ADVISORS INC something on the order of a couple of million shares each, which granted, isn't a lot of money--a pittance to that hedge fund group which wikipedia says has a fund, Nova fund, which can account for 10% of the trading on the Nasdaq sometimes. en.wikipedia.org Still, as shares are slowly heaped together, I would hope that would exert some pressure to move things in the right direction. Unless of course the DR program is going to start giving results, in which case the shares will take care of themselves.

To: Mike McFarland who wrote (1)	2/22/2008 10:11:19 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 50

$32.8 million on 12/31/07 and Not including the impact of the sale of the Genomics Assets, the cash burn rate for the first, second, third and fourth quarters was $7.0, $6.4, $5.1 and $3.1 million, respectively. Trending down, preserving cash (after blowing through $330M). Genomics Assets? Yeah, right. The sale didn't hardly look worth doing. I suppose it cuts the burn getting rid of it, but don't call it an asset. Anyway, it looks like they can hang on a couple more years-- do or die time for their repositioning program, and if they find something worth having that's great. Rah rah! I'm not listening to the CC now but maybe I'll listen to an archive later or look for a transcript. I don't have enough hope to tune in, all eager. Big questions should have been asked years ago, little late now. I still think a reverse merger for one of the companies that hasn't been able to IPO (Perlegen) or a similar company like Melior is a way out too. meliordiscovery.com